Danske Bank’s Xenon Pharmaceuticals XENE Stock Holding History

Danske Bank’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.04K	Hold	100	–	–	﹤0.01%	899
2026 Q1	$5.82K	Sell	100 -700	-88%	-$32.3K	﹤0.01%	895
2025 Q4	$35.9K	Hold	800	–	–	﹤0.01%	1078
2025 Q3	$32.1K	Hold	800	–	–	﹤0.01%	1098
2025 Q2	$25K	Buy	+800	New	+$26.1K	﹤0.01%	1146
2024 Q4	–	Sell	-100	Closed	-$3.94K	–	1671
2024 Q3	$3.94K	Buy	+100	New	+$4.03K	﹤0.01%	1448

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Danske Bank's XENE Position: Q2 2026 in Review

Danske Bank held its Xenon Pharmaceuticals (XENE) position steady in Q2 2026 at 100 shares worth $6.04K. The position accounts for ﹤0.01% of the portfolio, ranked #899.

Danske Bank first reported a position in XENE in Q3 2024 and has held it in 6 quarters since. The position peaked at $35.9K in Q4 2025. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

Danske Bank held 100 shares of Xenon Pharmaceuticals worth $6.04K as of Q2 2026.
Danske Bank left its Xenon Pharmaceuticals share count unchanged in Q2 2026.
Xenon Pharmaceuticals made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #899 holding.
Danske Bank first reported a position in Xenon Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
Danske Bank's Xenon Pharmaceuticals position peaked at $35.9K in Q4 2025.
315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.